Basilea Pharmaceutica Ltd. Logo
 
 
News and Media
 
 
Search
 ›› go!
 

Dermatology 2009

 
 
 

Alitretinoin

  • Alexandroff AB, Johnston GA. Medical management of contact dermatitis. G Ital Dermatol Venereol. 2009; 144(5): 537-540.
  • Batycka-Baran A, Baran W, Szepietowski J. Management of chronic hand eczema. Postepy Dermatol Alergol. 2009; 26(2): 84-91. 
  • Blome C, Maares J, Diepgen T, Jeffrustenbach S, Augustin M. Measurement of patient-relevant benefits in the treatment of chronic hand eczema - A novel approach. Contact Dermatitis. 2009; 61(1): 39-45.
  • English J, Aldridge R, Gawkrodger DJ, Kownacki S, Statham B, White JML, Williams J. Consensus statement on the management of chronic hand eczema. Clin Exp Dermatol. 2009; 34(7): 761-769.
  • Freemantle N, Aldridge R, Stanley G. Quality of life in chronic hand eczema as measured by the dermatology life quality index. Value Health. 2009; 12(7): A459.
  • Garnock-Jones KP, Perry CM. Alitretinoin in severe chronic hand eczema. Am J Clin Dermatol. 2009; 10(6): 421-422.  
  • Garnock-Jones KP, Perry CM. Alitretinoin: In severe chronic hand eczema. Drugs. 2009; 69(12): 1625-1634.
  • Ingram JR, Batchelor JM, Williams HC. Alitretinoin as a potential advance in the management of severe chronic hand eczema. Arch Dermatol. 2009; 145(3): 314-315.
  • Molin S, Ruzicka T. Possible benefit of oral alitretinoin in T-lymphoproliferative diseases: A report of two patients with palmoplantar hyperkeratotic-rhagadiform skin changes and mycosis fungoides or Sézary syndrome. Br J Dermatol. 2009; 161(6): 1420-1422.
  • Petersen B, Jemec GBE. Alitretinoin - Its use in intractable hand eczema and other potential indications. Drug Des Dev Ther. 2009; 3: 51-57.
  • Wollina U. Pompholyx or dyshidrosis. Expert Rev Dermatol. 2009; 4(4): 403-411.
     

18th Congress of the European Academy of Dermatology and Venereology EADV, October 2009, Berlin, Germany

  • P-246 / Development and validation of a questionnaire regarding satisfaction with treatment of disorders affecting the skin of the hands: the dermasat questionnaire. Alomar A, Ruiz M, Conde-Salazar L, de la Cuadra J, Heras F.
  • P-251 / Satisfaction with treatments for chronic hand eczema. Heras F, Ruiz M, Alomar A, Conde-Salazar L, de la cuadra J.
  • P-1148 / Succesful treatment of psoriasis pustulosa palmoplantaris using oral alitretinoin - a case report. Pföhler C, Müller CS, Tilgen, W.
  • P-1434 / Alitretinoin is well tolerated in the treatment of severe chronic hand eczema. Bissonnette R, Maares J, Ruzicka T.
  • P-1435 / Alitretinoin is effective in clearing severe chronic hand eczema. Hillen U, Harsch M, Kaszuba A, Elsner P, Ruzicka T.
  • P-1436 / Modified total lesion sympton score in chronic hand eczema is significantly reduced with alitretinoin treatment. Worm M, Brown T, Maares J, Jemec G.
  • P-1437 / Good correlation between patient and physician ratings of alitretinoin efficacy in chronic hand eczema. Coenraads P-J, Lynde C, Elsner P, Maares J.
  • P-1438 / The impact of chronic hand eczema on quality of life as measurement by the dermatology life quality index. Diepgen T, Ruzicka T, Maares J.
  • P-1447 / Oral alitretinoin in clinical pratice - case study of a difficult to treat patient with chronic vesicular hand eczema. English J, Bong J.
  • P-1452 / Remission of feet involvement in patients treated with alitretinoin for chronic hand eczema. Molin SC, Ruzicka T, Prinz JC.

 

 

Info